Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hybrid Trial for Alcohol Reduction Among People With TB and HIV in India (HATHI)

NCT04230395 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT04230395
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04230395 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hybrid Trial for Alcohol Reduction Among People With TB and HIV in India (HATHI)
Lead sponsor
Johns Hopkins University
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 22, 2022
Completion date
March 31, 2027
Enrollment
450 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, tuberculosis